Charming Medical Limited, through its subsidiaries, provides beauty and wellness services and products in Hong Kong. The company offers beauty, wellness, and postpartum services, including womb-warming therapy, agarwood moxibustion therapy, traditional chinese medicine (TCM) inspired prenatal massage, and indonesian traditional abdominal binding, as well as beauty, tailor-made, slim (BTS) pelvic detox therapy. It also provides TCM-inspired women's wellness services targeting women of different age groups through its wellness centers; non-hormonal induced lactation therapy, national moisturizing facial, saffron hip therapy, and natural reishi mushroom breast care; and japanese-style facial bone adjustment, needle-free thread embedding, and imperial chinese herbal acne detox therapy. In addition, the company offers TCM head/eyed care therapy services comprising ultrasound therapy, forehead cupping therapy, traditional herbal deer antler hair care, deep cleansing follicle therapy, japanese scalp cleansing, cell activation hair growth therapy, and TCM e-plus eye care therapy; and forehead and temples cupping, hair follicle deep cleaning, TCM deer antler hair care, and hair follicle activation therapies, as well as ultrasonic therapy device. Further, it provides Beauty Lab home herbal uterine care patch; probiotic intimate wash; Yin-nourishing pill; Ginseng soothing anti-allergy moisturizing wash; and southern european olive leaf extract for hair anti-aging and hair loss prevention. Additionally, the company is involved in the provision of consultancy services; and franchise activities. It serves women aged between twenty-five to fifty-five through online and offline channels. The company was founded in 2016 and is headquartered in Causeway Bay, Hong Kong. more
| Mar '23 | Mar '24 | Mar '25 | Mar '26 | |||
|---|---|---|---|---|---|---|
| Total Revenue | 3.53M | 6.02M | 6.22M | 4.81M | [{"date":"2023-03-31","value":56.75,"profit":true},{"date":"2024-03-31","value":96.68,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2026-03-31","value":77.27,"profit":true}] | |
| Cost of Revenue | 2.04M | 2.10M | 2.04M | 1.80M | [{"date":"2023-03-31","value":96.93,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":97.14,"profit":true},{"date":"2026-03-31","value":85.6,"profit":true}] | |
| Gross Profit | 1.49M | 3.91M | 4.18M | 3.01M | [{"date":"2023-03-31","value":35.74,"profit":true},{"date":"2024-03-31","value":93.63,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2026-03-31","value":71.98,"profit":true}] | |
| Gross Margin | 42.31% | 65.07% | 67.19% | 62.58% | [{"date":"2023-03-31","value":62.97,"profit":true},{"date":"2024-03-31","value":96.84,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2026-03-31","value":93.15,"profit":true}] | |
| Operating Expenses | 2.02M | 2.91M | 2.79M | 4.68M | [{"date":"2023-03-31","value":43.07,"profit":true},{"date":"2024-03-31","value":62.09,"profit":true},{"date":"2025-03-31","value":59.66,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] | |
| Operating Income | (521.34K) | 1.01M | 1.39M | 128.87K | [{"date":"2023-03-31","value":-37.53,"profit":false},{"date":"2024-03-31","value":72.63,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2026-03-31","value":9.28,"profit":true}] | |
| Total Non-Operating Income/Expense | (51.41K) | (175.60K) | (121.20K) | 4.59K | [{"date":"2023-03-31","value":-1119.4,"profit":false},{"date":"2024-03-31","value":-3823.25,"profit":false},{"date":"2025-03-31","value":-2638.73,"profit":false},{"date":"2026-03-31","value":100,"profit":true}] | |
| Pre-Tax Income | (420.47K) | 1.00M | 1.44M | 133.47K | [{"date":"2023-03-31","value":-29.3,"profit":false},{"date":"2024-03-31","value":69.92,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2026-03-31","value":9.3,"profit":true}] | |
| Income Taxes | (84.86K) | 181.75K | 236.08K | - | [{"date":"2023-03-31","value":-35.95,"profit":false},{"date":"2024-03-31","value":76.99,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2026-03-31","value":"-","profit":true}] | |
| Income After Taxes | (335.61K) | 821.74K | 1.20M | - | [{"date":"2023-03-31","value":-27.99,"profit":false},{"date":"2024-03-31","value":68.53,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2026-03-31","value":"-","profit":true}] | |
| Income From Continuous Operations | (335.61K) | 821.74K | 1.20M | (22.65K) | [{"date":"2023-03-31","value":-27.99,"profit":false},{"date":"2024-03-31","value":68.53,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2026-03-31","value":-1.89,"profit":false}] | |
| Income From Discontinued Operations | - | - | - | - | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true}] | |
| Net Income | (305.12K) | 777.81K | 1.20M | (22.65K) | [{"date":"2023-03-31","value":-25.45,"profit":false},{"date":"2024-03-31","value":64.87,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2026-03-31","value":-1.89,"profit":false}] | |
| EPS (Diluted) | - | - | - | - | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true}] | |
These ratios help you determine the liquidity of the company. Higher is better.
| MCTA | |
|---|---|
| Current Ratio | 1.89 |
| Quick Ratio | 1.88 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| MCTA | |
|---|---|
| ROA (LTM) | 0.89% |
| ROE (LTM) | -0.87% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| MCTA | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.48 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.52 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| MCTA | |
|---|---|
| Trailing PE | 419.36 |
| Forward PE | NM |
| P/S (TTM) | 92.67 |
| P/B | 10240.24 |
| EV/R | 80.79 |
| EV/Ebitda | 292.33 |
Charming Medical Limited Class A Ordinary Shares (MCTA) share price today is $0
Yes, Indians can buy shares of Charming Medical Limited Class A Ordinary Shares (MCTA) on Vested. To buy
Yes, you can purchase fractional shares of Charming Medical Limited Class A Ordinary Shares (MCTA) via the Vested app. You can start investing in Charming Medical Limited Class A Ordinary Shares (MCTA) with a minimum investment of $1.
You can invest in shares of Charming Medical Limited Class A Ordinary Shares (MCTA) via Vested in three simple steps:
The 52-week high price of Charming Medical Limited Class A Ordinary Shares (MCTA) is $31.7. The 52-week low price of Charming Medical Limited Class A Ordinary Shares (MCTA) is $4.3.
The price-to-earnings (P/E) ratio of Charming Medical Limited Class A Ordinary Shares (MCTA) is 419.3572
The price-to-book (P/B) ratio of Charming Medical Limited Class A Ordinary Shares (MCTA) is 10240.24
The dividend yield of Charming Medical Limited Class A Ordinary Shares (MCTA) is 0.00%
The market capitalization of Charming Medical Limited Class A Ordinary Shares (MCTA) is $445.55M
The stock symbol (or ticker) of Charming Medical Limited Class A Ordinary Shares is MCTA
Consider the share price of Charming Medical Limited Class A Ordinary Shares as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Charming Medical Limited Class A Ordinary Shares has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Charming Medical Limited Class A Ordinary Shares shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Charming Medical Limited Class A Ordinary Shares stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Charming Medical Limited Class A Ordinary Shares and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Charming Medical Limited Class A Ordinary Shares stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied
